MA1-118

antibody from Invitrogen Antibodies

Targeting: TUBB3 beta-4, CFEOM3, CFEOM3A, FEOM3

Provider product page for MA1-118

Western blot

Immunocytochemistry

Immunoprecipitation

Immunohistochemistry

Flow cytometry

Other assay

Antibody data

Antibody Data
Antigen structure
References [18]
Comments [0]
Validations
Immunocytochemistry [4]
Flow cytometry [1]
Other assay [12]

Submit

Product number: MA1-118 - Provider product page
Provider: Invitrogen Antibodies
Product name: beta-3 Tubulin Monoclonal Antibody (2G10)
Antibody type: Monoclonal
Antigen: Synthetic peptide
Description: MA1-118 was successfully used to detect E18 Sparague Dawley primary cortical neurons. MA1-118 can be used for immunofluorescence analysis of beta III tubulin in the ectoderm derived from human embryonic stem cells. Western blot analysis of MA1-118 detects an ~50 kDa protein in neuronal-type cells. In bovine, a unknown band at ~32 kDa is also detected. MA1-118 shows specificity to beta-3 Tubulin and is non-reactive to lysates from non-neuronal cell types (e.g. HeLa cell lysate).
Reactivity: Human, Mouse, Rat, Bovine, Guinea Pig, Hamster, Porcine, Rabbit
Host: Mouse
Isotype: IgG
Antibody clone number: 2G10
Vial size: 100 µg
Concentration: 1 mg/mL
Storage: -20°C

TUBB3 protein structure - MA1-118 shown in red.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescent analysis of beta-3 Tubulin in SHSY5Y cells (human neuroblast) either left untreated (left panel) or treated with 10uM retinoic acid (right panel) for 72 hours. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature. Cells were blocked with 1% Blocker BSA (Product # 37525) for 15 minutes at room temperature. Cells were probed without (left panel) or with (right panel) a beta-3 Tubulin monoclonal antibody (Product # MA1-118) at a dilution of 1:100 for at least 1 hour at room temperature, washed with PBS, and incubated with a DyLight 488-conjugated goat anti-mouse IgG secondary antibody (Product # 35502). F-Actin (red) was stained with DyLight-554 Phalloidin (Product # 21834) and nuclei (blue) were stained with Hoechst 33342 dye (Product # 62249). Images were taken on a Thermo Scientific ToxInsight at 20X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescent analysis of β-III tubulin in E18 Sparague Dawley primary cortical neuronal cells. The cells were fixed with 4% formaldehyde for 15 mins, permeabilized with 0.25% Triton X-100 in PBS for 10 mins, and blocked with 3% BSA in PBS for 30 mins at RT. Cells were stained with a β-III tubulin mouse monoclonal antibody (Product # MA1-118) at a dilution of 1:200 in 3% BSA in PBS for 1 hr at RT, and then incubated with Invitrogen™ AlexaFluor™ 555 Plus goat anti-mouse IgG secondary antibody (Product # A32727) at a dilution of 1:1000 for 1 hr at RT. Nuclei were stained with Hoechst 33342 (product # H3570). The image contains overlay of neuronal tubulin (orange) and nuclei (blue). Images were taken on a Zeiss LSM 710 confocal microscope at 40X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescence analysis of beta III tubulin (green) in the ectoderm derived from human ES cells. Embryoid bodies (EBs) were generated from the H9 embryonic stem cell line (WiCell Research Institute, WA09) using Gibco® KnockOut Serum Replacement. After four days in suspension culture, EBs were plated on Geltrex-coated tissue culture-treated polystyrene and continuously cultured for 21 days. EB cultures were then fixed and permeabilized according to the 3-Germ Layer Immunocytochemistry Kit (Product # A25538) and stained with anti-beta III-tubulin monoclonal antibody (Product # MA1-118, 1:200 dilution, 5 uL/mL final) at 4°C overnight. Secondary staining was completed using Alexa Fluor 488-conjugated anti-mouse IgG (Product # A-11001) and DAPI (Product # D1306) for nuclear DNA (blue) for 1 h at room temperature. Images were taken on EVOS® FL Auto Imaging System at 10X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescence analysis of beta-3 Tubulin was performed using 70% confluent log phase SH-SY5Y cells. The cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 10 minutes, and blocked with 1% BSA for 1 hour at room temperature. The cells were labeled with beta-3 Tubulin (2G10) Mouse Monoclonal Antibody (Product # MA1-118X) at 2µg/mL in 0.1% BSA and incubated for 3 hours at room temperature and then labeled with Goat anti-Mouse IgG (H+L) Superclonal™ Secondary Antibody, Alexa Fluor® 488 conjugate (Product # A28175) at a dilution of 1:2000 for 45 minutes at room temperature (Panel a: green). Nuclei (Panel b: blue) were stained with SlowFade® Gold Antifade Mountant with DAPI (Product # S36938). F-actin (Panel c: red) was stained with Rhodamine Phalloidin (Product # R415, 1:300). Panel d represents the merged image showing cytoplasmic localization. Panel e shows the no primary antibody control. The images were captured at 60X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunoprecipitation of beta-3 Tubulin was performed using SHSY5Y whole cell lysate. Antigen-antibody complexes were formed by incubating 300 µg of lysate with 5 µg of a beta-3 Tubulin monoclonal antibody (Product # MA1-118) overnight on a rocking platform at 4øC. The immune complexes were captured on 50 µL Protein A/G Agarose (Product # 20421), washed extensively, and eluted with 5X Lane Marker Reducing Sample Buffer (Product # 39000). SHSY5Y cell lysate (30 µg) was loaded as a positive control (left lane). The sample was resolved on a 4-20% Tris-HCl polyacrylamide gel, transferred to a PVDF membrane, and blocked with 5% BSA/TBS-0.1%Tween for at least 1 hour. The membrane was probed with a beta-3 Tubulin monoclonal antibody (Product # MA1-118) at a dilution of 1:1000 overnight rotating at 4øC, washed in TBST, and probed with Clean-blot IP Detection Reagent (Product # 21230) at a dilution of 1:1000 for at least 1 hour. Chemiluminescent detection was performed using SuperSignal West Pico (Product # 34080).

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Fig. 2 TGF-beta knockout improves functional recovery of mice after SCI. a Representative images of immunofluorescent analysis of 5-HT (red), beta-III-tublin (green) and DAPI (blue) in each group at 4 weeks after SCI. Scale bars = 200 mum. Right images are high-resolution versions of the boxed regions in the left images, scale bars = 50 um. b , c Quantitative analysis of intensity mean value of 5-HT and beta-III-tublin (* p < 0.05, ** p < 0.01, n = 4). d Quantitative analysis of BMS score between 13C4 control mice after SCI, 1D11 group mice after SCI and mice without SCI (* p < 0.05, ** p < 0.01, n = 6). e - h Quantitative analysis of catwalk, including print length, stride length, and print area (* p < 0.05, n = 6). LF left front paw, RF right front paw, RH right hind paw. Statistical significance was determined by multifactorial ANOVA, and all data are shown as means +- standard deviations.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 2 (a) Western blot analysis of protein extract from young and elderly keratinocytes with tubulin beta-3 chain. (b) Box plots of relative protein expression of tubulin beta-3 chain in young and elderly donors (based on western blot data by considering the relative intensity of the specific antibodies on the membrane versus the amount of protein loaded on the gel for young and elderly donors, * significant p value < 0.05 ( p value 0.0152)). (c) Receiver operating characteristic curve (ROC curve) with an AUC of 0.9048.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: 1 Figure Paclitaxel causes dose-dependent reduced neuronal networks in SH-SY5Y-derived neurons. Fully differentiated SH-SY5Y cells were treated with the indicated concentrations of paclitaxel for 24 hours. The cells were stained for beta-tubulin (TUBB3) and nuclei (DAPI). Scale bar represents 200 um.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: In situ HCR adaptation in axolotls (A) Classic digoxigenin-based enzymatic in situ hybridization using a probe for nrg1 . A' shows the sense probe for nrg1 . (B) An example of HCR in situ hybridization using a probe for nrg1. (C-E) A cross section of an uninjured tail stained for nrg1 mRNA. (F-H) A cross section of a regenerating tail 14 dpa probed for nrg1 mRNA. (I) Quantification of nrg1 signal in the uninjured and regenerating axolotl spinal cord showed no significant change between conditions. (I') Quantification of Nrg1 signal in the uninjured and regenerating axolotl spinal cord showed no significant change between conditions. (J-L) In situ HCR and IHC staining for mbp in red and TUBB3 in green in a cross section of an uninjured axolotl spinal cord. (M-O) In situ HCR and IHC staining for mbp in red and TUBB3 in green in a cross section of a brachial nerve in the axolotl forelimb. (P-R) In situ HCR and IHC staining for NRG1 in red and nrg1 in magenta in a cross section of an uninjured axolotl spinal cord. [Colour figure can be viewed at wileyonlinelibrary.com ]

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Fig. 6 SARS-CoV-2 antigens detection and cytokine/chemokine transcripts quantification in the olfactory system of hamsters. ( A-D ) Olfactory epithelium of mock- ( A, C ) and SARS-CoV-2 ( B, D ) infected hamsters at 4 dpi. Insets show infected OMP + mature olfactory sensory neurons ( B ), or infected Tuj1 + immature olfactory sensory neurons ( D ). The arrow in D indicates an infected Iba1+ cell. ( E ) Sagittal section showing nasal turbinates and olfactory bulb of SARS-CoV-2 infected hamster at 4 dpi. Inset depicts SARS-CoV-2 staining in olfactory sensory neuron axons. ( F ) Olfactory sensory axons projecting into glomeruli in the olfactory bulb of SARS-CoV-2 inoculated hamsters at 4 dpi. Insets ( F', F'' ) show infected cells. ( G-I ) Olfactory bulb of mock-( G ) or SARS-CoV-2 ( H, I ) infected hamsters at 4 dpi. Iba1 + infected cells are shown in ( H ) and several infected cells are observed in ( I ). SARS-CoV-2 is detected by antibodies raised against the viral nucleoprotein (NP). Scale bars: 20mum (A-D, H), 100mum (E, F), 50mum (G, I). Images are single z-planes (A-H) or maximum intensity projection over a 6mum depth (I). ( J ) Number of NP+ cells, NP+OMP+ cells, NP+Tuj1+ cells, NP+Iba1+, Iba1+ cells and cleaved caspase 3+ cells in the olfactory mucosa. ( K, L ) Number of NP+ cells in the olfactory nerve (K) and the olfactory bulb (L). ( M, N ) Cytokines and chemokines transcripts in the nasal turbinates ( M ) and in the olfactory bulb ( N ) at 2, 4 and 14 dpi. Mann-Whit

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Fig. 8 SARS-CoV-2 is present in the olfactory mucosa from patients with persistent loss of smell post-COVID-19 . ( A ) Clinical profile of the 4 patients with prolonged loss of smell post-COVID-19. The general symptoms at the acute phase and at the follow up (inclusion in CovidSmell study) are shown. ( B ) Immunofluorescence of infected cells in the olfactory mucosa of the case #10 presenting with persistent olfactory dysfunction at 196 days after COVID-19 onset. The left arrow indicates an infected cell with viral NP staining. The right arrow indicates a Tuj1-NP co-labeling in another cell. ( C ) Graph depicting the correlation between the IL-6 mRNA expression and the viral load in the 9 patients with acute COVID-19 (""acute"": n=5) or persistent olfactory dysfunction post-COVID-19 (""persistent"", n=4). ( D, E ) Fraction of infected cells among: Hoechst+ cells, OMP+ cells, Iba1+ cells and cleaved caspase 3+ cells (D), and fraction of Iba1+ cells among Hoechst+ cells (left), and fraction of cleaved caspase 3 + cells among Hoechst+ cells (right) in the olfactory mucosa of patients with persistent loss of smell post COVID-19 (n=4) and the patient #7 (post-COVID-19, persistent signs without loss of smell). ( E ) Viral load values were assessed by Taqman qPCR; when not quantifiable (nq:

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Effect of Abeta42 oligomers on neuronal cell toxicity. Primary cortical neurons were cultured from E17 rat embryos and after 7 days in vitro were exposed to a serial dilution of LMW or HMW Abeta42Os (1:200, 1:40, 1:20, and 1:10) for 24 ( A ), 48 ( B ), or 72 ( C ) h. At the end of incubation, cell viability was determined by LDH assay. Results are expressed as percentage of LDH release relative to control cells (dashed lines). Data are means +- SEM of 3 independent experiments, each performed in triplicate. * p < 0.05 versus control cells. Two-way ANOVA, followed by Tukey's multiple comparison test. ( D ) Primary neurons were treated with HMW Abeta42Os (1:10 dilution) for 24, 48, or 72 h. Cells were then processed for DAPI staining. Yellow arrows indicate cells with small, fragmented, and condensed nuclei. Experiments were performed 3 times and representative fluorescence microscopy images are shown. The scale bar is 10 um. ( E ) Primary neurons were treated with LMW or HMW Abeta42Os (1:10 dilution) for 24, 48, or 72 h. Cells were then processed for betaIII-tubulin immunostaining. Experiments were performed 3 times and representative fluorescence microscopy images are shown. The scale bar on the left is 50 um. In the zoomed images, the scale bar is 10 um. Quantification of neuritic beading, performed using ImageJ software, is shown at the bottom of the corresponding images. Data are means +- SEM from five random fields of 3 independent experiments. *** p < 0.001 versus contro

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Overview of connected deposition chambers. a Schematic representation of a dual deposition chamber connected with microchannels. b Schematic representation of the deposition chamber (DC) technology. Illustrations of the c side and d top views of the model indicating which dimensions of the structural components are used to calibrate the flow profile within the culture compartments. e Immunofluorescent pictures of 18 DIV embryonic rat hippocampal with anti-BIII-Tubulin (Green) and with DAPI (bleu), seeded in a 10 5 rectangular deposition chamber (DC1) connected via 450 mum long microchannels with another (DC2). Image was obtained using a x10 objective. The scale bar represents 500 um

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Fig. 3 SMARCA4 represses Otx2 / c-MYC induced Group 3 medulloblastoma. a DAPI staining and Smarca4 immunofluorescence of sagittal brain tumor section of CD1 mouse 3 months after transfection with pPBase + pPBMyc + pPBGfi1 + pPBVenus at P0. b DAPI staining and Smarca4 immunofluorescence of sagittal brain tumor section of CD1 mouse 1 month after transfection with pPBase + pPBMyc + pPBOtx2 + pPBVenus at P0. c Western blot of brain tumors of CD1 mice after transfection with pPBase + pPBMyc + pPBGfi1 + pPBVenus (GM) and pPBase + pPBMyc + pPBOtx2 + pPBVenus (OM). d Kaplan-Meier survival curve of mice injected at P0 with Otx2 + c-Myc and Otx2 + c-Myc + Smarca4. e Kaplan-Meier survival curve of mice injected at P0 with Gfi1 + c-Myc and Gfi1 + c-Myc + Smarca4. f - h Confocal images of GFP (Venus) and Ki67 ( f ), beta3-tubulin ( g ), GFAP ( h ) immunofluorescence of transfected cell clusters in CD1 mouse 10 days after transfection with pPBase + pPBMyc + pPBOtx2 + pPBVenus at P0. The white squares in ( f , g , h ) mark the region shown at higher magnification in ( f ', g ', h '). i - k Confocal images of GFP (Venus) and Ki67 ( i ), beta3-tubulin ( j ), GFAP ( k ) immunofluorescence of transfected cell clusters in CD1 mouse 10 days after transfection with pPBase + pPBMyc + pPBOtx2 + pPBSmarca4 + pPBVenus at P0. The white squares in ( i , j , k ) mark the region shown at higher magnification in ( i ', j ', k '). Arrows point to double-positive cells. Scale bars 100 um.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Fig. 4 Cerebellar organoids electroporation with Gfi1 / c-MYC and Otx2 / c-MYC induces overproliferation. a Schematic representation of organoids electroporation. b Brightfield and fluorescence images of cerebellar organoids at day 60 electroporated at day 35 with pPBVenus. c Brightfield and fluorescence images of cerebellar organoids at day 60 electroporated at day 35 with pPBase + pPBMyc + pPBGfi1 + pPBVenus. d Brightfield and fluorescence images of cerebellar organoids at day 60 electroporated at day 35 with pPBase + pPBMyc + pPBOtx2 + pPBVenus. Arrows in ( b , c , d ) indicate Venus-positive cells. e Confocal images of GFP (Venus) and PCNA immunofluorescence of cerebellar organoids at day 60 electroporated at day 35 with pPBase + pPBVenus + pPBMyc and pPBOtx2. Arrows indicate double-positive cells. f Confocal images of GFP (Venus) and beta3-tubulin immunofluorescence of cerebellar organoids at day 60 electroporated at day 35 with pPBase + pPBMyc + pPBOtx2 + pPBVenus. Arrows indicate beta3-tubulin-negative cells. g Quantification of cerebellar organoids at day 60, electroporated at day 35 with either pPBVenus or pPBase + pPBMyc + pPBOtx2 + pPBVenus (OM) or pPBase + pPBMyc + pPBGfi1 + pPBVenus (GM). n = 6 biologically independent organoids. h Quantification of cerebellar organoids at day 40, electroporated at day 35 with either pPBVenus or pPBase + pPBMyc + pPBOtx2 + pPBVenus (OM) or pPBase + pPBMyc + pPBGfi1 + pPBVenus (GM). n = 6 biologically independent organoids. Error